Treatments for partial remission of major depressive disorder: a systematic review and meta-analysis

Question Partial remission of major depressive disorder (MDD) is a debilitating and distressing clinical state related to chronicity, morbidity and relapse. Although one-third of patients remit partially, evidence for treatment efficacy is unclear. We provide an overview of treatment options and the...

Full description

Saved in:
Bibliographic Details
Main Authors: Marlies E Brouwer, Gert J Geurtsen, Damiaan A J P Denys, Joost Gülpen, Eva A M van Dis, Claudi L Bockting
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:BMJ Mental Health
Online Access:https://mentalhealth.bmj.com/content/26/1/1.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823864121671548928
author Marlies E Brouwer
Gert J Geurtsen
Damiaan A J P Denys
Joost Gülpen
Eva A M van Dis
Claudi L Bockting
author_facet Marlies E Brouwer
Gert J Geurtsen
Damiaan A J P Denys
Joost Gülpen
Eva A M van Dis
Claudi L Bockting
author_sort Marlies E Brouwer
collection DOAJ
description Question Partial remission of major depressive disorder (MDD) is a debilitating and distressing clinical state related to chronicity, morbidity and relapse. Although one-third of patients remit partially, evidence for treatment efficacy is unclear. We provide an overview of treatment options and their efficacy.Study selection and analysis Embase, PsycINFO, Medline and SCOPUS were systematically searched through February 2023. Included were randomised controlled trials (RCTs) examining any treatment in patients with partially remitted MDD aged 13–65 years, reporting data on severity, remission or relapse.Findings Seven RCTs examining psychotherapy including 1024 patients were eligible. There were not enough RCTs to examine effects of pharmacotherapy. Psychotherapy was associated with lower depressive symptom severity at post-treatment (Hedges’ g=0.50; 95% CI 0.23 to 0.76), but not at follow-up up to 1 year (Hedges’ g=0.36; 95% CI −0.30 to 1.02) or longer (Hedges’ g=0.02; 95% CI −0.09 to 0.12). Psychotherapy was associated with superior remission rates at post-treatment (OR 2.57; 95% CI 1.71 to 3.87) and follow-up 6 months or longer (OR 1.75; 95% CI 1.21 to 2.53), although not with improved relapse rates at post-treatment (OR 0.17; 95% CI 0.01 to 4.83) or follow-up 6 months or longer (OR 0.46; 95% CI 0.21 to 1.03). Overall methodological quality was poor.Conclusions Psychotherapy targeting partial remission may be effective in lowering depressive symptom severity and patients may potentially achieve full remission twice as likely. Yet, long-term and prophylactic effects are lacking. Given the risk of chronicity, more high-quality RCTs are needed.PROSPERO registration number CRD42020188451.
format Article
id doaj-art-d8eae7e7f678478da7ac15fe9062f429
institution Kabale University
issn 2755-9734
language English
publishDate 2023-11-01
publisher BMJ Publishing Group
record_format Article
series BMJ Mental Health
spelling doaj-art-d8eae7e7f678478da7ac15fe9062f4292025-02-09T05:55:09ZengBMJ Publishing GroupBMJ Mental Health2755-97342023-11-0126110.1136/bmjment-2023-300827Treatments for partial remission of major depressive disorder: a systematic review and meta-analysisMarlies E Brouwer0Gert J Geurtsen1Damiaan A J P Denys2Joost Gülpen3Eva A M van Dis4Claudi L Bockting52 Mental Health, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands3 Department of Medical Psychology, Amsterdam UMC Location AMC, Amsterdam, The NetherlandsPsychiatry, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands1 Department of Psychiatry, Amsterdam UMC Location AMC, Amsterdam, The Netherlands1 Department of Psychiatry, Amsterdam UMC Location AMC, Amsterdam, The Netherlands1 Department of Psychiatry, Amsterdam UMC Location AMC, Amsterdam, The NetherlandsQuestion Partial remission of major depressive disorder (MDD) is a debilitating and distressing clinical state related to chronicity, morbidity and relapse. Although one-third of patients remit partially, evidence for treatment efficacy is unclear. We provide an overview of treatment options and their efficacy.Study selection and analysis Embase, PsycINFO, Medline and SCOPUS were systematically searched through February 2023. Included were randomised controlled trials (RCTs) examining any treatment in patients with partially remitted MDD aged 13–65 years, reporting data on severity, remission or relapse.Findings Seven RCTs examining psychotherapy including 1024 patients were eligible. There were not enough RCTs to examine effects of pharmacotherapy. Psychotherapy was associated with lower depressive symptom severity at post-treatment (Hedges’ g=0.50; 95% CI 0.23 to 0.76), but not at follow-up up to 1 year (Hedges’ g=0.36; 95% CI −0.30 to 1.02) or longer (Hedges’ g=0.02; 95% CI −0.09 to 0.12). Psychotherapy was associated with superior remission rates at post-treatment (OR 2.57; 95% CI 1.71 to 3.87) and follow-up 6 months or longer (OR 1.75; 95% CI 1.21 to 2.53), although not with improved relapse rates at post-treatment (OR 0.17; 95% CI 0.01 to 4.83) or follow-up 6 months or longer (OR 0.46; 95% CI 0.21 to 1.03). Overall methodological quality was poor.Conclusions Psychotherapy targeting partial remission may be effective in lowering depressive symptom severity and patients may potentially achieve full remission twice as likely. Yet, long-term and prophylactic effects are lacking. Given the risk of chronicity, more high-quality RCTs are needed.PROSPERO registration number CRD42020188451.https://mentalhealth.bmj.com/content/26/1/1.full
spellingShingle Marlies E Brouwer
Gert J Geurtsen
Damiaan A J P Denys
Joost Gülpen
Eva A M van Dis
Claudi L Bockting
Treatments for partial remission of major depressive disorder: a systematic review and meta-analysis
BMJ Mental Health
title Treatments for partial remission of major depressive disorder: a systematic review and meta-analysis
title_full Treatments for partial remission of major depressive disorder: a systematic review and meta-analysis
title_fullStr Treatments for partial remission of major depressive disorder: a systematic review and meta-analysis
title_full_unstemmed Treatments for partial remission of major depressive disorder: a systematic review and meta-analysis
title_short Treatments for partial remission of major depressive disorder: a systematic review and meta-analysis
title_sort treatments for partial remission of major depressive disorder a systematic review and meta analysis
url https://mentalhealth.bmj.com/content/26/1/1.full
work_keys_str_mv AT marliesebrouwer treatmentsforpartialremissionofmajordepressivedisorderasystematicreviewandmetaanalysis
AT gertjgeurtsen treatmentsforpartialremissionofmajordepressivedisorderasystematicreviewandmetaanalysis
AT damiaanajpdenys treatmentsforpartialremissionofmajordepressivedisorderasystematicreviewandmetaanalysis
AT joostgulpen treatmentsforpartialremissionofmajordepressivedisorderasystematicreviewandmetaanalysis
AT evaamvandis treatmentsforpartialremissionofmajordepressivedisorderasystematicreviewandmetaanalysis
AT claudilbockting treatmentsforpartialremissionofmajordepressivedisorderasystematicreviewandmetaanalysis